sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
gaggcuuaugaaaugccuuca | 1680 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1423 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1423 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1387 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1387 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1644 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaggcuuaugaaaugccuuca | 1644 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 306 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 306 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 756 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 756 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 486 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 486 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 36 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cccaguuucuugagaucugca | 36 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauugaacaguauauuucagga | 2709 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauugaacaguauauuucagga | 2709 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacauucucccaaguuauucagc | 2739 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacauucucccaaguuauucagc | 2739 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaggacuuucaaaggccaagga | 1555 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaggacuuucaaaggccaagga | 1555 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaggacuuucaaaggccaagga | 1591 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaggacuuucaaaggccaagga | 1591 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcccagucaugacauuucucaa | 2589 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcccagucaugacauuucucaa | 2589 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agagagaaaugguaaguuuca | 3186 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agagagaaaugguaaguuuca | 3186 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agagagaaaugguaaguuuca | 2121 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agagagaaaugguaaguuuca | 2121 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guguuucuucccuuaauauuuau | 2732 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guguuucuucccuuaauauuuau | 2732 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caugagacuaugcaccuauaaau | 1184 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caugagacuaugcaccuauaaau | 1184 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1115 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1115 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 233 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 233 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1577 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1577 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 683 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 683 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1613 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaccuaagugacuaccacuuau | 1613 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagccuaagaaauaucuuugcu | 2574 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gaagccuaagaaauaucuuugcu | 2574 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagcacauauuagcacauucaag | 2649 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagcacauauuagcacauucaag | 2649 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uguuuuggaaccuacauagagga | 1058 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uguuuuggaaccuacauagagga | 1058 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uguuuuggaaccuacauagagga | 1332 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uguuuuggaaccuacauagagga | 1332 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1751 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1751 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1494 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1494 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1537 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1537 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1794 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuauuuauaggugcauaguuuca | 1794 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1007 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1007 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 826 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 826 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 556 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 556 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 106 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 106 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1281 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1281 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1824 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 1824 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 376 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuacauagagaacacccucuuuu | 376 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cugcucuuccauggcguacaagu | 1164 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cugcucuuccauggcguacaagu | 1164 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 65 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 65 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 515 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 515 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 1218 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 1218 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 944 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 944 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 335 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 335 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 785 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaucccaucucacuuuaaua | 785 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagggaagaaacacuuuaaagga | 2485 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagggaagaaacacuuuaaagga | 2485 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagggaagaaacacuuuaaagga | 3550 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagggaagaaacacuuuaaagga | 3550 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaaaucuaccuaaagcagcaua | 717 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaaaucuaccuaaagcagcaua | 717 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaaaucuaccuaaagcagcaua | 267 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuaaaucuaccuaaagcagcaua | 267 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguauuca | 2874 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguauuca | 2874 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gauacugucuaagaauaauga | 1920 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gauacugucuaagaauaauga | 1920 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gauacugucuaagaauaauga | 2985 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.